| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 105.6 | 87.6 | 52.2 |
| Other income | 0.0 | 0.1 | 0.0 |
| Total income | 105.7 | 87.6 | 52.2 |
| Profit before exceptional items & tax | 23.5 | 13.7 | 12.4 |
| Profit before tax | 23.5 | 13.7 | 12.4 |
| Net profit | 17.2 | 8.3 | 9.3 |
| Operating margin | 22.2% | 15.6% | 23.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +84.90% |
|---|---|
| Net profit, quarter on quarter | +107.20% |
| Revenue, year on year | +102.30% |
| Operating profit, year on year | +89.50% |
| Operating profit, quarter on quarter | +72.80% |
NSE results filing, NSE: AHCL. Figures extracted from the filing.
Anlon Healthcare Ltd: key numbers
- Share price
- ₹25.29
- Market cap
- ₹134.4 Cr
- Revenue (annual)
- ₹172.0 Cr
- Net profit (annual)
- ₹28.51 Cr
- P/E (TTM)
- 4.2×Sector 46.1×
- Promoter holding
- 52.68%+0.00% QoQ
- FII holding
- 0.99%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anlon Healthcare Ltd
All →Anlon Healthcare Preferential Issue
Anlon Healthcare received NSE and BSE in-principle approval for 8,05,35,651 preferential shares under a share swap. No cash consideration is stated.
Anlon Healthcare Board Meeting Date
Anlon Healthcare will hold a board meeting on 29 October 2026 to consider unaudited standalone and consolidated half-yearly results. The trading window is closed from 1 October to 31 October 2026.
Anlon Healthcare Other Announcement
Anlon Healthcare Limited filed the mandatory Regulation 74(5) certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.
Anlon Healthcare Fund Raise of ₹250 Cr
Anlon Healthcare approved a preferential issue of convertible warrants for up to Rs. 250 Crore to raise funds for the company.
- Value
- ₹250.0 Cr
Anlon Healthcare Board Meeting Date
Anlon Healthcare Ltd scheduled a board meeting for October 13, 2026, to deliberate on business expansion plans and potential fund-raising.
Anlon Healthcare Merger & Restructuring
Anlon Healthcare incorporated ANLON Healthcare Nigeria Limited, holding 90% stake. The subsidiary aims to expand pharmaceutical and healthcare operations across 16 West African countries.